_id

690f389cccc777a4e85d1877

Ticker

BRTX

Name

BioRestorative Therapies Inc

Exchange

NASDAQ

Address

40 Marcus Drive, Melville, NY, United States, 11747

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.biorestorative.com

Description

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.

Last Close

1.11

Volume

29717

Current Price

1.11

Change

0

Last Updated

2025-11-28T13:09:16.039Z

Image

data:image/webp;base64,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

Ipo Date

2007-07-27T00:00:00.000Z

Market Cap

9763866

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8414285714285714

Sentiment Sources

7

Rating

4.5

Target Price

13

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

11800

Cost Of Revenue

63189

Gross Profit

-51390

Operating Expenses

3657621

Operating Income

-3709011

Interest Expense

-

Pretax Income

-3038277

Net Income

-3038277

Eps

-0.3332842995941718

Dividends Per Share

-

Shares Outstanding

8876242

Income Tax Expense

-

EBITDA

-2985657

Operating Margin

-31432.296610169495

Total Other Income Expense Net

670734

Cash

602444

Short Term Investments

3887383

Receivables

13400

Inventories

-

Total Current Assets

4699973

Property Plant Equipment

309498

Total Assets

5642662

Payables

859898

Short Term Debt

-

Long Term Debt

-

Total Liabilities

3435683

Equity

2206979

Depreciation

52620

Change In Working Capital

355988

Cash From Operations

-2901137

Capital Expenditures

3

Cash From Investing

1997638

Cash From Financing

-49308

Net Change In Cash

-952807

PE

-

PB

4.584978343699691

ROE

-137.66678341751327

ROA

-53.84474561829151

FCF

-2901140

Fcf Percent

-245.8593220338983

Piotroski FScore

1

Health Score

20

Deep Value Investing Score

1.5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

1.5

Growth Investing Score

1

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

1.5

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

11800

Quarters > 0 > income Statement > cost Of Revenue

63189

Quarters > 0 > income Statement > gross Profit

-51390

Quarters > 0 > income Statement > operating Expenses

3657621

Quarters > 0 > income Statement > operating Income

-3709011

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-3038277

Quarters > 0 > income Statement > net Income

-3038277

Quarters > 0 > income Statement > eps

-0.3332842995941718

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

9116172

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-2985657

Quarters > 0 > income Statement > operating Margin

-31432.296610169495

Quarters > 0 > income Statement > total Other Income Expense Net

670734

Quarters > 0 > balance Sheet > cash

602444

Quarters > 0 > balance Sheet > short Term Investments

3887383

Quarters > 0 > balance Sheet > receivables

13400

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

4699973

Quarters > 0 > balance Sheet > property Plant Equipment

309498

Quarters > 0 > balance Sheet > total Assets

5642662

Quarters > 0 > balance Sheet > payables

859898

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

3435683

Quarters > 0 > balance Sheet > equity

2206979

Quarters > 0 > cash Flow > net Income

-3038277

Quarters > 0 > cash Flow > depreciation

52620

Quarters > 0 > cash Flow > change In Working Capital

355988

Quarters > 0 > cash Flow > cash From Operations

-2901137

Quarters > 0 > cash Flow > capital Expenditures

3

Quarters > 0 > cash Flow > cash From Investing

1997638

Quarters > 0 > cash Flow > cash From Financing

-49308

Quarters > 0 > cash Flow > net Change In Cash

-952807

Quarters > 0 > ratios > PE

-0.3332842995941718

Quarters > 0 > ratios > PB

4.584978343699691

Quarters > 0 > ratios > ROE

-137.66678341751327

Quarters > 0 > ratios > ROA

-53.84474561829151

Quarters > 0 > ratios > FCF

-2901140

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-245.8593220338983

Quarters > 0 > health Score

20

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

303300

Quarters > 1 > income Statement > cost Of Revenue

8729

Quarters > 1 > income Statement > gross Profit

294571

Quarters > 1 > income Statement > operating Expenses

3599858

Quarters > 1 > income Statement > operating Income

-3305287

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-2656263

Quarters > 1 > income Statement > net Income

-2656263

Quarters > 1 > income Statement > eps

-0.30390696882584767

Quarters > 1 > income Statement > dividends Per Share

73743

Quarters > 1 > income Statement > shares Outstanding

8740382

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-2603513

Quarters > 1 > income Statement > operating Margin

-1089.7748104187274

Quarters > 1 > income Statement > total Other Income Expense Net

649024

Quarters > 1 > balance Sheet > cash

1555251

Quarters > 1 > balance Sheet > short Term Investments

5825685

Quarters > 1 > balance Sheet > receivables

15000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

7597807

Quarters > 1 > balance Sheet > property Plant Equipment

339681

Quarters > 1 > balance Sheet > total Assets

8516559

Quarters > 1 > balance Sheet > payables

609931

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

3671235

Quarters > 1 > balance Sheet > equity

4845324

Quarters > 1 > cash Flow > net Income

-2656263

Quarters > 1 > cash Flow > depreciation

52748

Quarters > 1 > cash Flow > change In Working Capital

89274

Quarters > 1 > cash Flow > cash From Operations

-2693867

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

2132191

Quarters > 1 > cash Flow > cash From Financing

888138

Quarters > 1 > cash Flow > net Change In Cash

326462

Quarters > 1 > ratios > PE

-0.30390696882584767

Quarters > 1 > ratios > PB

2.002306557827712

Quarters > 1 > ratios > ROE

-54.82116366212043

Quarters > 1 > ratios > ROA

-31.189392335566513

Quarters > 1 > ratios > FCF

-2693867

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-8.881856247939334

Quarters > 1 > health Score

30

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

25000

Quarters > 2 > income Statement > cost Of Revenue

2909

Quarters > 2 > income Statement > gross Profit

22091

Quarters > 2 > income Statement > operating Expenses

4829625

Quarters > 2 > income Statement > operating Income

-4807534

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-5339799

Quarters > 2 > income Statement > net Income

-5339799

Quarters > 2 > income Statement > eps

-0.6389502967700804

Quarters > 2 > income Statement > dividends Per Share

102799

Quarters > 2 > income Statement > shares Outstanding

8357143

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-4755753

Quarters > 2 > income Statement > operating Margin

-19230.136

Quarters > 2 > income Statement > total Other Income Expense Net

-532265

Quarters > 2 > balance Sheet > cash

1228789

Quarters > 2 > balance Sheet > short Term Investments

7884132

Quarters > 2 > balance Sheet > receivables

25000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

9355321

Quarters > 2 > balance Sheet > property Plant Equipment

369992

Quarters > 2 > balance Sheet > total Assets

10326821

Quarters > 2 > balance Sheet > payables

599500

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

4182080

Quarters > 2 > balance Sheet > equity

6144741

Quarters > 2 > cash Flow > net Income

-5339799

Quarters > 2 > cash Flow > depreciation

51781

Quarters > 2 > cash Flow > change In Working Capital

-31214

Quarters > 2 > cash Flow > cash From Operations

-2778786

Quarters > 2 > cash Flow > capital Expenditures

36400

Quarters > 2 > cash Flow > cash From Investing

2366967

Quarters > 2 > cash Flow > cash From Financing

1092718

Quarters > 2 > cash Flow > net Change In Cash

680899

Quarters > 2 > ratios > PE

-0.6389502967700804

Quarters > 2 > ratios > PB

1.5096533328255823

Quarters > 2 > ratios > ROE

-86.90031036295916

Quarters > 2 > ratios > ROA

-51.708061948589986

Quarters > 2 > ratios > FCF

-2815186

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-112.60744

Quarters > 2 > health Score

31

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

43300

Quarters > 3 > income Statement > cost Of Revenue

3339

Quarters > 3 > income Statement > gross Profit

39961

Quarters > 3 > income Statement > operating Expenses

2730103

Quarters > 3 > income Statement > operating Income

-2690142

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-1636148

Quarters > 3 > income Statement > net Income

-1636148

Quarters > 3 > income Statement > eps

-0.21073703376072844

Quarters > 3 > income Statement > dividends Per Share

131325

Quarters > 3 > income Statement > shares Outstanding

7763932

Quarters > 3 > income Statement > income Tax Expense

3

Quarters > 3 > income Statement > EBITDA

-2639773

Quarters > 3 > income Statement > operating Margin

-6212.799076212471

Quarters > 3 > income Statement > total Other Income Expense Net

1053994

Quarters > 3 > balance Sheet > cash

547890

Quarters > 3 > balance Sheet > short Term Investments

10184701

Quarters > 3 > balance Sheet > receivables

188400

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

11144221

Quarters > 3 > balance Sheet > property Plant Equipment

362936

Quarters > 3 > balance Sheet > total Assets

12279799

Quarters > 3 > balance Sheet > payables

483070

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

3748406

Quarters > 3 > balance Sheet > equity

8531393

Quarters > 3 > cash Flow > net Income

-1636148

Quarters > 3 > cash Flow > depreciation

50369

Quarters > 3 > cash Flow > change In Working Capital

88591

Quarters > 3 > cash Flow > cash From Operations

-2347845

Quarters > 3 > cash Flow > capital Expenditures

12434

Quarters > 3 > cash Flow > cash From Investing

1532607

Quarters > 3 > cash Flow > cash From Financing

-126316

Quarters > 3 > cash Flow > net Change In Cash

-941554

Quarters > 3 > ratios > PE

-0.21073703376072844

Quarters > 3 > ratios > PB

1.010147407346022

Quarters > 3 > ratios > ROE

-19.17797011578297

Quarters > 3 > ratios > ROA

-13.323898868377244

Quarters > 3 > ratios > FCF

-2360279

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-54.509907621247116

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.3332842995941718

Valuation > metrics > PB

4.584978343699691

Valuation > final Score

34.150216563003085

Valuation > verdict

52.8% Overvalued

Profitability > metrics > ROE

-137.66678341751327

Profitability > metrics > ROA

-64.64456285174404

Profitability > metrics > Net Margin

-257.48110169491525

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.5567357007021816

Risk > metrics > Interest Coverage

-70.48671607753705

Risk > final Score

-252

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.465733145093953

Liquidity > metrics > Quick Ratio

5.465733145093953

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-203

Prev Risks > 1

15

Prev Risks > 2

49

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T12:41:01.163Z